logo
episode-header-image
Yesterday
19m 39s

Strategic Dealmaking in Health: Navigati...

PwC's Health Industries
About this episode

Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Nick Donkar, PwC’s U.S. Health Services Deals Leader, and Roel Van den Akker, PwC’s Pharma and Life Sciences Deals Leader, to discuss the 2025 midyear deals outlook across health services and pharma and life sciences. They explore how macroeconomic trends, regulatory pressures, and evolving investment strategies are shaping M&A activity and where new opportunities may emerge as companies look ahead to the second half of the year.
 
 Discussion highlights:
 

  • Health services deal volume remains resilient, with renewed investor interest in behavioral health, physician groups, and home-based care models
  • Private equity firms are focused on outpatient growth platforms and niche services like revenue cycle management to navigate cost and regulatory headwinds
  • Pharma and life sciences dealmaking is centered on targeted, asset driven M&A in the $1 to $5 billion range, rather than full scale platform acquisitions
  • Regulatory uncertainty from FDA resource constraints to evolving policies on pricing and probability of technical and regulatory success (PTRS), is complicating deal modeling and slowing transaction timelines
  • U.S. biopharma companies are increasingly sourcing early stage innovation from China, introducing new strategic opportunities along with cross border compliance and data challenges

Speakers:

Glenn Hunzinger, Health Industries Leader, PwC
Nick Donkar, US Healthcare Deals Leader
Roel Van den Akker, US Pharma & Life Sciences Deals Leader
 
Linked materials:

https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html

https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html


For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Up next
Jun 3
Taking a closer look at the Most Favored Nation Pricing Executive Order
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healt ... Show More
16m 47s
May 23
Navigating the FDA disruption: 4 key actions for pharma
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Matt Rich, PwC’s Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in th ... Show More
10m 5s
May 22
Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader and Roel van den Akker, PwC’s Pharma and Life Sciences Deals Leader discuss the rapid rise of China’s biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech ... Show More
11m 46s
Recommended Episodes
Feb 2014
Better health through integrated care (SOP7)
As our nation strives to improve health outcomes for all Americans, APA and its Center for Psychology and Health are working to expand psychology’s role in health care by improving access to psychological and behavioral health services, particularly in primary care settings. In t ... Show More
8m 57s
Dec 2023
Healthcare Upside/Down: Strategic Metrics and Autonomy: Navigating the New Era of Healthcare Integration with CFO Nick Barcellona and ECG Partners Dan Harrison and Malita Scott
Welcome to "Healthcare Upside Down," a podcast by Becker's Healthcare and ECG Management Consultants. Join Molly Gamble, along with Nick Barcellona, CFO at WVU Medicine, Dan Harrison, partner with ECG, and Malita Scott, partner with ECG, as they explore the upsides and downsides ... Show More
13m 54s
Nov 2023
Episode 77: Analyzing Rising Healthcare Costs in the US: the Role of Palliative Care and Advocacy
Please listen to and watch this latest episode of The Lebanese Physicians' Podcast with Dr. Lama El Zein MD, MHA. Dr. El Zein just started a position as Vice President, Quality and Implementation Science at Hackensack Meridian Health in New Jersey. In this episode, we discuss the ... Show More
32m 43s
Oct 2017
#64 Stuff You Should Know About Health Policy
Get schooled on medical homes, payer reform, and what the future might look like for primary care with Dr. Sue Bornstein, MD, FACP and Executive Director of the Texas Medical Home Initiative and Chair of the Health and Public Policy Committee at the ACP. Dr Alex Lane of Cooper Un ... Show More
49m 42s
Mar 2023
#204 - Concierge medicine takes a personalized, preventive approach | Chloe Harrouche & Mike Haney
Concierge medicine can help personalize healthcare and disrupt the traditional primary care model. Traditional primary care isn’t positioned to handle the frequent check ins and actionable steps that empower patients to optimize their health and wellness. Chloe Harrouche and Mike ... Show More
48 m
Aug 2023
Episode 70: Enhancing Access to Primary Care and the Role of Medical Informatics
Please listen to our latest episode of The Lebanese Physicians' Podcast discussing clincial informatics in primary care and its role in enhancing access to primary care and preventive care. This episode is co-hosted with Dr. MohammadAli Jardaly. Our guest is Dr. Ramy Khalil who i ... Show More
56m 50s
Apr 2024
Episode 86: Access to Healthcare in the US: The Role of PicassoMD with Dr. Reza Sanai
Please listen to and watch our latest episode of The Lebanese Physicians’ Podcast with Dr. Reza Sanai. Reza is married to a great Lebanese pediatrician in the DMV area Dr. Nadine Idriss and is a cardiologist by training, and a healthcare entrepreneur whose goal is to make healthc ... Show More
31m 56s